Global Blood Therapeutics latest biotech to double in debut

Blood disorder drug developer Global Blood Therapeutics shares more than doubled Wednesday as the company became the latest biotechnology company to get a powerful response from investors in its stock market debut.

Genome-editing proteins seek and find with a slide and a hop

Searching a whole genome for one particular sequence is like trying to fish a specific piece from the box of a billion-piece puzzle. Using advanced imaging techniques, University of Illinois researchers have observed how ...

A turning point in the physics of blood

Mike Graham knows that fluid dynamics can reveal much about how the flow of blood helps and hinders individual blood cells as they go about their work.

Study confirms controversial nitrite hypothesis

Understanding how nitrite can improve conditions such as hypertension, heart attack and stroke has been the object of worldwide research studies. New research from Wake Forest University has potentially moved the science ...

Faster, cheaper tests for sickle cell disease

Within minutes after birth, every child in the U.S. undergoes a battery of tests designed to diagnose a host of conditions, including sickle cell disease. Thousands of children born in the developing world, however, aren't ...

Scientists use light to uncover the cause of sickle cell disease

In sickle cell disease, hemoglobin—the oxygen-carrying component of blood—forms fibers that stiffen red blood cells and cause life-threatening symptoms. Using light-scattering techniques to study the detailed thermodynamics ...

Computer models shed new light on sickle cell crisis (w/ video)

Using powerful computer models, researchers from Brown University have shown for the first time how different types of red blood cells interact to cause sickle cell crisis, a dangerous blockage of blood flow in capillaries ...

page 9 from 10